MediWound Ltd.(MDWD)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

MediWound Ltd. (MDWD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MDWD at 28.0/100 on a 32-signal composite quality model, placing it at rank #2,569 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), MediWound Ltd. reports quarterly revenue of $17.0M, net income of $-23.9M. Top institutional holders of MDWD by reported 13-F value include INVESTOR AB, Yelin Lapidot Management Ltd., Rosalind Advisors, based on the most recent SEC filings. MDWD trades on the Nasdaq exchange and files with the SEC under CIK 1593984. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDWD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MediWound Ltd. directly from SEC EDGAR.